CVS stands for chorionic villus sampling. The doctor takes a tiny sample from the placenta, specifically chorionic villi, because that tissue usually carries the same genetic material as the baby. The sample is then tested for chromosome problems or specific DNA changes.

CVS is usually done between 10 and 13 weeks of pregnancy. That timing is the main reason it is discussed. It gives diagnostic information earlier than amniocentesis, which is more commonly done between 15 and 20 weeks.

CVS is usually chosen when a family needs an early diagnostic answer. Common reasons include a high-risk first-trimester screen, a positive NIPT, advanced maternal age, a known family history of a single-gene disorder, or a previous baby affected by a genetic condition.

The practical advantage is timing. If the result is needed early for planning, counseling, or difficult pregnancy decisions, CVS can provide that information weeks before amniocentesis. In India, this discussion usually happens with an OB-GYN, fetal medicine specialist, and genetic counselor.

CVS is done at 10 to 13 weeks and uses placental tissue. Amniocentesis is done later, usually at 15 to 20 weeks, and uses amniotic fluid. Both are diagnostic tests and can confirm many chromosome conditions rather than only estimate risk.

The tradeoff is timing versus procedure risk. CVS gives an earlier answer, which some families strongly value. Amniocentesis is slightly safer overall. CVS also does not detect neural tube defects directly, so the anatomy scan still matters even if CVS is normal.

In transabdominal CVS, a thin needle is passed through the abdomen into the placenta under ultrasound guidance. This is the more common route in many Indian centers and is often preferred because infection risk is lower than the cervical route.

In transcervical CVS, a thin catheter is passed through the cervix to reach the placenta. Only some centers use this regularly. The route depends on placental location, operator experience, and what is safest in that pregnancy. Ultrasound guidance is essential in both methods.

Most CVS procedures take about 5 to 10 minutes once positioning is complete. The area may be cleaned and local anesthesia may be used, especially for the abdominal route. Many women describe pressure, brief cramping, or a period-like pulling sensation rather than sharp pain.

Recovery is usually simple. Most doctors advise taking it easy for the rest of the day, avoiding heavy lifting and sex for about 24 hours, and watching for bleeding, strong cramping, fever, or leaking fluid. Mild spotting or mild cramps can happen, but worsening symptoms need a call to the hospital.

The main concern is miscarriage. A practical counseling range for CVS is about 0.5 to 1 percent, which is slightly higher than the usual amniocentesis range of about 0.1 to 0.3 percent. The exact number depends on center experience and how complex the procedure is.

Infection is rare. Rh-negative mothers may need anti-D after the procedure to reduce sensitization risk. A very rare limb reduction problem is linked to procedures done before 10 weeks, which is why experienced units avoid early CVS and keep it within the standard 10 to 13 week window.

In India, rapid tests such as FISH or QF-PCR may give an early answer in about 3 to 5 days, often for major trisomies. These rapid tests commonly cost around Rs 3,000 to Rs 6,000 depending on the lab and hospital.

A full karyotype usually takes around 10 to 14 days and may cost roughly Rs 5,000 to Rs 10,000. Chromosomal microarray can cost around Rs 15,000 to Rs 30,000. These tests are usually coordinated through tertiary fetal medicine units in cities such as Delhi, Mumbai, and Chennai.

Access is not uniform across India. CVS is usually available in tertiary fetal medicine centers rather than smaller hospitals. Government institutions such as AIIMS, PGI, and JIPMER may offer the procedure free or heavily subsidized when indicated.

Private hospital groups such as Apollo, Fortis, and Nova may charge roughly Rs 10,000 to Rs 30,000 for the procedure itself, with genetics testing billed separately in some cases. Volume and operator expertise matter, so families are usually advised to choose a center that performs these procedures regularly.

A positive CVS result should be followed by clear genetic counseling. In India, this often involves fetal medicine specialists and counselors working with ISMG-aligned practice standards. The goal is to explain what the finding means, what is certain, and what remains uncertain.

Families then discuss pregnancy options, follow-up scans, and legal timelines. Under the MTP Act 2021, serious fetal anomaly decisions may remain legally possible up to 24 weeks with the required process, including Medical Board review in relevant situations. The final decision is personal and often emotionally demanding.

For many low-risk pregnancies, NIPT is the easier first test. It is a maternal blood test that can be done from 10 weeks and usually costs about Rs 15,000 to Rs 30,000 in India. It has no invasive procedure risk and performs very well for common trisomies.

But NIPT is still a screening test, not a diagnosis. If NIPT is positive, or if a family needs a definite answer for a known disorder, CVS becomes important. The usual sequence in India is NIPT first for low-risk reassurance, then CVS only when diagnostic confirmation is needed.